GlassScriptPhysician profile
Scott M Hibbets
NPI 1215193776
$3,452.64
in general payments reported to CMS, 2019-2025
14 companies · $520 in 2025
The $520 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $125 · 2021: $232 · 2022: $1,018 · 2023: $390 · 2024: $540 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Entertainment: $79.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.34 |
| Entertainment | $79.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $828.52 | 2019-2025 | Total30, Precision7, Precision 1 |
| Coopervision INC. | $766.20 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $443.24 | 2022-2025 | Infuse, Biotrue One Day, Biotrue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $395.19 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $202.34 | 2022-2025 | Cequa |
| Oyster Point Pharma, INC. | $183.98 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $170.05 | 2020-2022 | |
| Rxsight INC | $129.60 | 2022 | |
| Maculogix, INC. | $125.10 | 2019 | |
| Optos, INC. | $109.44 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $48.18 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $21.00 | 2024 | |
| Shire North American Group INC | $16.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hibbets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.